FEASIBILITY STUDY OF MAGNETIC RESONANCE IMAGINING APPLICATION IN EXPERIMENTAL RADIOLOGY FOR INTRAVITAL VERIFICATION OF LUNGS METASTASES IN MICE

Cover Page

Cite item

Full Text

Abstract

Background. For preclinical studies of radiopharmaceuticals there is a high need for development new methods of in vivo metastasis diagnosis in mice after tumor cells transplantation. The study was carried out to assess feasibility of lung metastasis diagnosis with magnetic resonance imaging (MRI) visualization in mice C57Bl6.
The aim of this study was to assess feasibility of MRI for verification of distant metastases of the solid B16-F10 melanoma with validation by anatomic dissection.
Methods. Metastatic lesions were caused by injection of B16-F10 murine melanoma cells into cavum medullare of the tibia. Imaging studies were performed on the 21th day after transplantation using 7T magnetic resonance tomograph, coronal and axial images were acquired. Validation of metastasis was made by anatomic dissection and histological examination.
Results. MRI method enables visualization of lung nodules with diameter at least 0.8 mm, because smaller nodules cannot be distinguished from heartbeat artifacts. Histological examination revealed that macroscopic anatomic dissection can precisely detect subpleural lung nodules.
Conclusion. This study demonstrated feasibility of in vivo lung metastasis verification with MRI method in mice: metastases comparable in diameter to the size of large bronchi can be detected by MRI as well as by ex vivo dissection. For centrally located lung metastasis MRI method is preferable because macroscopic dissection enables to visualize only nodules which are located subpleurally.

About the authors

A. V. Smirnova

N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia; A.S. Loginov Moscow Clinical Scientific Center, Moscow Healthcare Department

Author for correspondence.
Email: smirn-ova@mail.ru
ORCID iD: 0000-0003-0386-9732

Anna Vyacheslavna Smirnova

24 Kashirskoe Shosse, Moscow 115478

86 Entuziastov Shosse, Moscow 111123

Russian Federation

P. O. Varaksa

N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia

ORCID iD: 0000-0003-0106-8384

24 Kashirskoe Shosse, Moscow 115478

Russian Federation

Yu. A. Finogenova

N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia

ORCID iD: 0000-0002-5144-1039

24 Kashirskoe Shosse, Moscow 115478

Russian Federation

Yu. A. Lagodzinskaya

N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia

ORCID iD: 0000-0001-6260-0763

24 Kashirskoe Shosse, Moscow 115478

Russian Federation

A. A. Lipengolts

N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia; A.I. Burnazyan Federal Medical Biophysical Center, FMBA of Russia; National Research Nuclear University MEPhI (Moscow Engineering Physics Institute)

ORCID iD: 0000-0002-5631-9016

24 Kashirskoe Shosse, Moscow 115478

46 Zhivopisnaya St., Moscow 123098

31 Kashirskoe Shosse, Moscow 115409

Russian Federation

M. A. Abakumov

N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia; National University of Science and Technology “MISIS”

ORCID iD: 0000-0003-2622-9201

1 Ostrovityanova St., Moscow 117997

4 Leninskiy Ave., Moscow 119049

Russian Federation

E. Yu. Grigorieva

N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia

ORCID iD: 0000-0001-7726-7991

24 Kashirskoe Shosse, Moscow 115478

Russian Federation

References

  1. Rizzo L., Rijcken C., Pola R. et al. Multimodal imaging of breast cancer metastasis targeting and antimetastatic nanotherapy. Mol Imaging Biol 2016;18(Suppl 1):675–6.
  2. Marien E., Hillen A., Swinnen J.V., Vande Velde G. The value of micro-CT to monitor lung metastasis in an immune-competent mouse cancer model. Bruker microCT user meeting Proceedings 2016;12:37–40.
  3. Tatum J.L., Kalen J.D., Jacobs P.M. et al. A spontaneously metastatic model of bladder cancer: imaging characterization. Transl Med 2019;17(1):425. doi: 10.1186/s12967-019-02177-y.
  4. Kertész I., Vida A., Nagy G. et al. In vivo imaging of experimental melanoma tumors using the novel radiotracer 68Ga-NODAGA-Procainamide (PCA). J Cancer 2017;8(5):774–85. doi: 10.7150/jca.17550.
  5. Al Faraj A., Shaik A.S., Halwani R., Alfuraih A. Magnetic targeting and delivery of drug-loaded SWCNTs theranostic nanoprobes to lung metastasis in breast cancer animal model: noninvasive monitoring using magnetic resonance imaging. Mol Imaging Biol 2016;18(3): 315–24. doi: 10.1007/s11307-015-0902-0.
  6. Numata T., Kiryu S., Maeda T. et al. A pulmonary metastatic model of murine melanoma assessed by magnetic resonance imaging. Exp Dermatol 2017;26(7): 619–21. doi: 10.1111/exd.13327.
  7. Wang F., Akashi K., Murakami Y. et al. Detection of lung tumors in mice using a 1-Tesla compact magnetic resonance imaging system. PLoS One 2014;9(4):e94945. doi: 10.1371/journal.pone.0094945.
  8. Blocker S.J., Mowery Y.M., Holbrook M.D. et al. Bridging the translational gap: implementation of multimodal small animal imaging strategies for tumor burden assessment in a co-clinical trial. PLoS One 2019;14(4):e0207555. doi: 10.1371/journal.pone.0207555.
  9. Park S.I., Kim S.J., McCauley L.K., Gallick G.E. Pre-clinical mouse models of human prostate cancer and their utility in drug discovery. Curr Protoc Pharmacol 2010;51:14.15.1–14.15.27. doi: 10.1002/0471141755.ph1415s51.
  10. Zelenevskiy N.V. International Veterinary Anatomical Nomenclature in Latin and Russian. Nomina Anatomica Veterinaria. 5th edn. SaintPetersburg: Lan, 2013. 399 p. (In Russ.).
  11. Varaksa P.O., Dyachenko I.A., Kalabina E.A., Stafford V.V. Methods of preparation of biological material for histological research. Textbook. Ed by P.O. Varaksa. Moscow: Publisher FSBEI of APE RAPS AIC, 2020. 140 p. (In Russ.).

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c)



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС77-53039 от  04.03.2013.